مرکز تحقیقات عفونت‌های منتقله از خون

جهاد دانشگاهی خراسان رضوی

EN | FA

مقالات همایش

دوشنبه ، 13 آبان 1398

  1. Hepatitis C Virus Infection Awareness-raising Through HepC Mobile Application and Hepatobot, 4th Shiraz International Congress on Mobile Health, Shiraz, Iran, 16-18 February 2021
  2. Rapid point-of-care testing of HCV infection and non-invasive testing of liver fibrosis: a preliminary study of addict populations in Mashhad, The 28th Iranian Congress on Infectious Disease and Tropical Medicine, Tehran, Iran, 11 -15 January 2020
  3. Assessment the activity of HTLV-1 in HAM/TSP patients using Tax mRNA expression and proviral load after in vitro lymphocyte activation, The 3rd International Neuroinflammation Congress & The 3rd Student Festival of Neuroscience, Mashhad, Iran, 11-13 June 2019
  4. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), and expression of CXCR3 and CCR6 and their ligands on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis, The 3rd International Neuroinflammation Congress & The 3rd Student Festival of Neuroscience, Mashhad, Iran, 11-13 June 2019
  5. Comparing the prevalence of viral blood borne infections between inhabitants and travelers referred to blood centers in Mashhad, The 1th National Congress on Management and Control of Blood Borne Infections, Mashhad, Iran, 24-26 October 2018
  6. Prevalence of hepatitis B core antibody seropositivity and occult hepatitis B in blood donors of Mashhad, The 1th National Congress on Management and Control of Blood Borne Infections, Mashhad, Iran, 24-26 October 2018
  7. An epidemiologic update on HTLV-1 infection in Eastern Mediterranean and Middle Eastern countries, The HTLV European Research Network (HERN) Meeting, Beirut, Lebanon, 29-30 June 2018
  8. HTLV-1 in Iran: Assessing knowledge of healthcare providers and medical sciences students, The HTLV European Research Network (HERN) Meeting, Beirut, Lebanon, 29-30 June 2018
  9. Comparison of IL-12, IL-18 and IFN-γ gene expression in HTLV-1-associated myelopathy ⁄ tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers and HTLV-1 negative individuals, The 14th International Congress of Immunology & Allergy, Tehran, Iran, 26-28 April 2018
  10. Autoimmune hepatitis in a person with HTLV-1 seropositivity: a rare coincident, The 2nd International and 10th National Iranian Neurogenetic Congress, Mashhad, Iran, 21-23 February 2018
  11. Occult hepatitis B virus infection among hemodialysis patients of Iran: a systematic review and meta-analysis, The Viral Hepatitis Congress, Sari, Iran, 14-15 December 2017
  12. A review on the last Iranian schedule and guideline of Immunization (2015), The Viral Hepatitis Congress, Sari, Iran, 14-15 December 2017
  13. Knowledge of viral hepatitis in Mashhad, Iran: a community-based survey, Birjand Hepatitis Conference (BHC1), Birjand, Iran, 10 September 2017
  14. Prevalence of HBV/HCV coinfection in Mashhad, northeast of Iran, Birjand Hepatitis Conference (BHC1), Birjand, Iran, 10 September 2017
  15. A review on last Iranian schedule and guideline of HBV immunization (2015), The 7th International Tehran Hepatitis Congress, Tehran, Iran, 6-8 September 2017
  16. A systematic review and meta-analysis for estimation of occult hepatitis B virus Infection prevalence among different population of Iran, The 7th International Tehran Hepatitis Congress, Tehran, Iran, 6-8 September 2017
  17. Prevalence of hepatitis D virus infection in individuals with hepatitis B surface antigenemia in Mashhad, northeast of Iran, The 7th International Tehran Hepatitis Congress, Tehran, Iran, 6-8 September 2017
  18. Introducing surrogate markers using serological, molecular and liver markers for evaluating of HCV clinical manifestation, The 9th International Congress of Laboratory and Clinic and The 2nd National Congress of Basic Medical Sciences & Knowledge-based Production, Tehran, Iran, 21-24 February 2017
  19. Evaluation of immune markers profile of HTLV-1 infected people in northeast of Iran, The 3th International Congress of Immuonology, Asthma and Allergy, Mashhad, Iran, 3-6 May 2016
  20. Evaluation of autoimmune markers in HTLV-1 carriers compared with uninfected people, The 13th International Congress of Immunology & Allergy of Iran, Tabriz, Iran, 26-29 April 2016
  21. Evaluation of hepatitis B e antigen and related antibodies to find an appropriate surrogate marker for the viral load determination in diagnosis of HBV infection, The 13th International Congress of Immunology & Allergy of Iran, Tabriz, Iran, 26-29 April 2016
  22. Evaluation of hepatitis B e antigen and liver function tests to find an appropriate surrogate marker for the viral load in diagnosis of HBV infection, The 8th International Congress of Laboratory and Clinic and 1st National Congress on Medical Basic Sciences & Knowledge-based production, Tehran, Iran, 6-8 February 2016
  23. Introducing a mathematical algorithm for predicting viral load in HBV infected subjects using surrogate markers, The 6th International Tehran Hepatitis Congress, Tehran, Iran, 27-29 May 2015
  24. The prevalence of Hepatitis B surface Antigen-positivity among pregnant women admitted to a great medical laboratory in Mashhad, 2009-2010, The 7th International Congress of Laboratory and Clinic and 1st Conference of Clinical Virology, Tehran, Iran, 12-15 February 2015
  25. Assessment of HTLV-1 infection risk factors in first-time blood donors in Mashhad, Iran: a case-control study, The 23rd Iranian Congress on Infectious Diseases and Tropical Medicine, Tehran, Iran, 12-16 January 2015
  26. No evidence of HIV infection among general population of Mashhad, Northeast of Iran, The 23rd Iranian Congress on Infectious Diseases and Tropical Medicine, Tehran, Iran, 12-16 January 2015
  27. Systematic review and meta-analysis on HTLV-I Infection in multi-transfused patients of Iran, The 21st International Student Congress of (bio)Medical Sciences (ISCOMS), Groningen, The Netherlands, 3-6 June 2014
  28. Prevalence of hepatitis A virus (HAV) infection in Mashhad, northeast of Iran: a population-based survey, The 5th International Tehran Hepatitis Congress, Tehran, Iran, 15-17 May 2013
  29. Population movement and virus spreading: HEV spreading in a pilgrimage city, Mashhad in northeast Iran, as an example, The 5th International Tehran Hepatitis Congress, Tehran, Iran, 15-17 May 2013
  30. Distribution of Hepatitis C virus genotypes and the viral load in patients with thalassemia and hemophilia in Mashhad, Northeast of Iran, The 5th International Tehran Hepatitis Congress, Tehran, Iran, 15-17 May 2013
  31. High prevalence of HTLV-1 infection among hemodialysis patients in Neyshabour, northeast of Iran, The 2nd International Congress of Immunology, Asthma and Allergy, Tehran, Iran, 19-21 February 2013
  32. Needle stick injuries and post-exposure practices among hospital personnel in Mashhad, Iran, The 6th Iranian Congress of Clinical Microbiology & the 1st International Congress of Clinical Microbiology, Mashhad, Iran, 2-4 October 2012
  33. Assessment of sexual high-risk behaviors in college students in Mashhad, northeastern Iran, The International Congress on HIV/AIDS Women & Children, Shiraz, Iran, 3-4 May 2012
  34. No molecular evidence of HTLV-II infection among seroindeterminate samples in Mashhad, northeast of Iran, The 11st International Congress of Immunology & Allergy of Iran, Tehran, Iran, 26-29 April 2012
  35. Prevalence of hepatitis C virus infection in Mashhad, northeast Iran, The 4th International Tehran Hepatitis congress, Tehran, Iran, 23-25 November 2011
  36. Evaluation of medical sciences students’ knowledge regarding HTLV in Mashhad, 2011, The 7th Annual Research Congress of Eastern Medical Sciences students, Mashhad, Iran, 16-18 November 2011
  37. Needle stick injuries and post-exposure practices among hospital personnels in Mashhad, northeastern Iran, The 12th Annual Research Congress of Iranian Medical Sciences students & 4th International Congress of Medical Sciences students, Isfahan, Iran, 6-9 September 2011
  38. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran, The 3rd International Tehran Hepatitis Congress, Tehran, Iran, 6-8 October 2010
  39. A systematic review for estimation of HTLV infection in the blood donors in Iran, The 1st International Conference of EBM in Developing Countries, Tabriz, Iran, 20-23 April 2010
  40. Is HTLV-1 infection associated with ABO and Rhesus blood group types?, The 1st International Congress of HTLV-1 and  Related Diseases in Iran, Mashhad, Iran, 18-20 February 2010
  41. HTLV-1 epidemiology in Neyshabour, Northeast of Iran, The 1st International Congress of HTLV-1 and  Related Diseases in Iran, Mashhad, Iran, 18-20 February 2010
  42. An optimized cut-off point for ELISA test in detection of HTLV-1 infection, The 1st International Congress of HTLV-1 and Related Diseases in Iran, Mashhad, Iran, 18-20 February 2010
  43. Seroepidemiology of HTLV-I in Iran: an overview, The 1st International Congress of HTLV-1 and  Related Diseases in Iran, Mashhad, Iran, 18-20 February 2010
  44. HTLV- I infection in the general population of Mashhad, Iran: prevalence and risk factors, The 1st International Congress of HTLV-1 and  Related Diseases in Iran, Mashhad, Iran, 18-20 February 2010
  45. Prevalence of health related high-risk behaviors among college students in Mashhad, 2008, the 10th Students’ International Conference on Biomedical and Interdisciplinary Research, Mashhad, Iran, 19-22 may 2009
  46. Psychologic symptoms in HIV-infected patients in Khorasan Razavi Province, Iran, 2006-2007, The 19th Annual Meeting of Society for Virology, Leipzig, German, 18 March 2009
  47. Evaluation of in vitro efficacy of some current disinfectants in Iran against hepatitis B virus, The 19th Annual Meeting of Society for Virology, Leipzig, German, 18 March 2009
  48. Knowledge, attitudes and practice of physicians toward HIV/AIDS in Mashhad, 2007, The 1st Annual AIDS Research Congress of Iran, Tehran, Iran, 11 November 2007
  49. Knowledge and attitudes towards HIV/AIDS in Iranian young people, The 7th International Congress on AIDS in Asia and the Pacific, Japan, 1-5 July 2005